
Lunaris Pharma Private Limited
Founded in 2024 and headquartered in West Bengal, India.
Founded in 2024 and headquartered in West Bengal, India.
Lunaris Pharma Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 December 2024 ( three months 6 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pradip Sachan and Shalini Sachan serve as directors at the Company.
Kolkata, West Bengal, India
+91-XXXXXXXXXX
U21001WB2024PTC275083
275083
Private Limited Indian Non-Government Company
12 Dec 2024
-
-
Unlisted
Roc-Kolkata
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pradip Sachan ![]() | Director | 12-Dec-2024 | Current |
Shalini Sachan ![]() | Director | 12-Dec-2024 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Lunaris Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Pradip Sachan and Shalini Sachan are mutual person
Pradip Sachan and Shalini Sachan are mutual person
Pradip Sachan is a mutual person
Pradip Sachan and Shalini Sachan are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Lunaris Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lunaris Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lunaris Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pradip Sachan was appointed as a Director was appointed as a Director on 12 Dec 2024 & has been associated with this company since 3 months 6 days .
Shalini Sachan was appointed as a Director was appointed as a Director on 12 Dec 2024 & has been associated with this company since 3 months 6 days .
Lunaris Pharma Private Limited was registered on 12 Dec 2024 with RoC-Kolkata & aged 3 months 6 days as per MCA records.
Lunaris Pharma Private Limited was incorporated on 12 Dec 2024.
The authorized share capital of Lunaris Pharma Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Lunaris Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Lunaris Pharma Private Limited is 31/41 Binova Bhave Road 8 Da, Mani Tower Sahapur, Kolkata, West Bengal, India, 700038.
The corporate identification number (CIN) of Lunaris Pharma Private Limited is U21001WB2024PTC275083 and the company number is 275083 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.